This opportunity is no longer accepting applications.
grant PAR-21-136

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

This grant opportunity focuses on early-stage testing of new drug or device-based treatments for mental disorders, requiring clinical trials. Applicants should use an experimental therapeutics approach that explores both the clinical effects of the intervention and the underlying mechanisms of the disorder or treatment response. The goal is to test interventions with new mechanisms of action a…

This is a reissue of RFA-MH-18-703: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required). NIMH requires an experimental therapeutics approach for the development and testing of therapeutic interventions, in which …

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Open for Submission: March 2, 2021
Submission Deadline: October 15, 2024
Application Window Closes: October 15, 2024
Opportunity Released: March 2, 2021

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.